1. Gastroenterology. 2023 Feb;164(2):300-303.e3. doi:
10.1053/j.gastro.2022.10.010.  Epub 2022 Oct 19.

Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against 
SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients 
After 3 Doses of COVID-19 Vaccine.

Liu Z(1), Alexander JL(2), Lin KW(3); VIP Study Investigators; Ahmad T(4), 
Pollock KM(3), Powell N(5).

Collaborators: Le K, Zhou X, Ibraheim H, Anandabaskaran S, Saifuddin A, 
McFarlane LR, Anand N, Constable L, Seoane RC, D'Mello A, Balarajah S, Hicks LC, 
Williams HRT, Lo JW, Hart AL, Altmann DM, Boyton RJ, Teare JP, Nice R, Bewshea 
C, Goodhand JR, Kennedy NA, Barnes A, Kirkwood J, Parkinson M, Gardner-Thorpe H, 
Lees CW, Jones GR, Covil K, Derikx L, Fiorentino F, Irving PM, Parkes M, Linger 
R, Kok K, Lee I, Cipriano B, Patel KV, Sebastian S, Kent AJ, Chukwurah I, Haq S, 
Shah P, Wilken-Smith S, Ramanathan A, Patel M, Romanczuk L, King R, Domingo J, 
Knight B, Shamtally D, Mendoza V, Sanchez J, Stark H, Bee L, Estember C, Watkins 
D, Stone S, Alcalde BG, Ruocco G, Baden M, Cooke G, Kourampa E, Pasquale C, 
Robisco-Diaz E, Bhatti S.

Author information:
(1)Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, 
Imperial College London, London, United Kingdom.
(2)Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, 
Imperial College London, London, United Kingdom, and, Department of 
Gastroenterology, Imperial College Healthcare NHS Trust, London, United Kingdom.
(3)Department of Infectious Disease, Faculty of Medicine, Imperial College 
London, London, United Kingdom.
(4)Royal Devon University Healthcare NHS Foundation Trust, Exeter, United 
Kingdom.
(5)Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, 
Imperial College London, London, United Kingdom, and, Department of 
Gastroenterology, Imperial College Healthcare NHS Trust, London, United Kingdom. 
Electronic address: npowell@imperial.ac.uk.

DOI: 10.1053/j.gastro.2022.10.010
PMCID: PMC9578965
PMID: 36270334 [Indexed for MEDLINE]